The clinical pedigree of the scaffold is difficult to overstate. Celecoxib, the archetypal COX-2 selective anti-inflammatory, ruxolitinib, the JAK inhibitor that transformed myelofibrosis care, and crizotinib, the ALK inhibitor that reshaped treatment of ALK-positive lung cancer, all carry the pyrazole core. According to the review, more than 30 pyrazole-containing drugs have been approved by the U.S. Food and Drug Administration since 2011, targeting diseases as varied as cancer, cystic fibrosis, HIV, rheumatoid arthritis and hereditary angioedema. Recent additions to that list include lenacapavir, a long-acting HIV capsid inhibitor; berotralstat, a kallikrein inhibitor for hereditary angioedema; and pirtobrutinib, a non-covalent BTK inhibitor designed for patients who have progressed on covalent predecessors. Each new approval reinforces the argument that the ring’s electronic configuration, hydrogen-bonding capability and conformational mimicry give medicinal chemists an unusually versatile handle on biological targets.

What explains this durability at the molecular level? The review devotes careful attention to the structural logic of the scaffold. Pyrazole’s aromaticity arises from delocalized pi-electrons across the five-membered ring, and the two nitrogen atoms exert a profound influence on polarity, dipole moment and reactivity. The N-H group acts as a hydrogen bond donor while the adjacent pyridine-like nitrogen serves as an acceptor, allowing the ring to engage enzymatic pockets in multiple orientations. Electrophilic substitution proceeds preferentially at C-4, while nucleophilic substitution favours C-3 and C-5, and tautomerism between the nitrogens adds a further layer of chemical adaptability. Because the ring can also serve as a bio-isostere for other aromatic systems, substituting pyrazole into a lead molecule often improves pharmacokinetic and pharmacodynamic behaviour simultaneously, a rare combination in scaffold-hopping exercises.

The heart of the review is its catalogue of newly synthesized derivatives and their measured activities, and the numbers are striking. Anwer and colleagues reported azobenzene-linked pyrazole-pyrimidine hybrids in which the leading compound achieved sub-micromolar cytotoxicity across four tumour cell lines, with IC50 values between 5.12 and 6.77 micromolar, while potently inhibiting VEGFR-2 at 0.90 micromolar and the resistant EGFR T790M mutant at 0.25 micromolar, outperforming erlotinib and matching sorafenib. Xu and co-workers fused pyrazole onto the natural product matrine, producing a derivative that killed Huh-7 hepatocellular carcinoma cells at 5.92 micromolar by inducing apoptosis, arresting cells in G0/G1 and suppressing JAK/STAT signalling in a dose-dependent manner. These are not incremental tweaks to known chemotypes; they represent deliberate re-engineering of how the scaffold engages intracellular machinery.

Selectivity, the perennial challenge of oncology drug design, emerges as a defining theme of the 2025-2026 cohort. Kou and colleagues built dihydropyrimidinone-pyrazole hybrids targeting the SHP2 phosphatase and achieved selectivity indices as high as 475.44 against MIA PaCa-2 pancreatic cancer cells relative to normal cells, meaning the compounds are hundreds of times more toxic to tumours than to healthy tissue. Fadaly’s group introduced oxime and nitrate moieties that enable covalent docking to the Cys797 residue of the double-mutant EGFR L858R/T790M, yielding IC50 values of 0.031 to 0.076 micromolar and selectivity windows comparable to osimertinib, the clinical standard for this mutation. Meanwhile, Abd El-Karim’s benzofuran-pyrazole hybrids displayed multi-kinase inhibition across B-Raf V600E, EGFR, VEGFR-2, c-Met and Pim-1 with GI50 values spanning 0.33 to 4.87 micromolar on the NCI-60 panel, all while remaining non-lethal to cells at much higher concentrations.

The review also highlights a delivery innovation that may prove as consequential as any single molecule. Aljohani and colleagues encapsulated pyrazole and pyrimidine derivatives within chitosan-polyvinyl alcohol nanogels and observed dramatic potency gains: cytotoxicity improved by 31.82 percent against A549 lung cancer cells, 40.12 percent against HCT116 colon cells, 50.00 percent against HepG2 liver cells and 52.61 percent against MCF-7 breast cancer cells, while all formulations retained IC50 values above 48 micromolar against normal VERO cells. The compounds function as topoisomerase-II inhibitors and DNA intercalators, and the nanogel vehicle appears to overcome transport barriers that limit intracellular entry of the free molecules. This pairing of rational small-molecule design with polymeric formulation points toward a hybrid strategy in which scaffold optimization and delivery engineering advance in lockstep rather than in sequence.

Infectious disease and agriculture feature prominently in the new data as well. Zalaru’s team achieved minimum inhibitory concentrations of 0.023 micrograms per millilitre against Staphylococcus aureus, an extraordinary potency figure, without cytotoxicity toward normal fibroblasts. Alenazi and Alnoman’s pyrazole-thiazole hybrids showed broad-spectrum inhibition of S. aureus, E. coli and Candida albicans with MIC values as low as 3.125 micrograms per millilitre, occasionally surpassing standard antibiotics, while Saadon’s 5-hydroxy pyrazole carbothioamide suppressed bacterial biofilm formation by 96.17 percent, on par with gentamicin. Keerthi’s pyrazole-oxadiazole hybrids matched ethambutol against Mycobacterium tuberculosis H37Rv with an MIC of 1.56 micrograms per millilitre. On the agricultural side, Huang’s benzophenone-linked pyrazole carboxamides outperformed the commercial fungicide bixafen against Sclerotinia sclerotiorum with an EC50 of 4.11 micrograms per millilitre, and Chu’s sulfonamide-oxadiazole hybrids beat boscalid against Valsa mali, disrupting hyphal ultrastructure and plasma membrane integrity in ways that translated to effective protection of apple fruits in vivo.

Metabolic and inflammatory pipelines show equally disciplined structure-activity logic. Sura and colleagues coupled pyrazole to isatin-triazole spacers to produce DPP-4 inhibitors, with the lead compound achieving 87.95 percent enzyme inhibition at an IC50 of 1.56 nanomolar, comparable to sitagliptin and teneligliptin, through pi-pi stacking with TYR666 and PHE357 in the active cavity. Elgohary’s sulfonamide celecoxib analogues inhibited COX-2 at 0.05 micromolar and, in a formalin-induced paw edema model, reduced TNF-alpha by 71.43 percent and PGE2 by 77.11 percent, outperforming both celecoxib and indomethacin with normal liver, kidney and cardiac parameters. Feng’s neuroprotective pyrazoles suppressed IL-6 expression in stimulated microglial cells at 9.562 micromolar, exceeding dexamethasone and celecoxib, offering a candidate for the secondary inflammation that follows spinal cord injury. Akocak’s arylazo pyrazole carboxamides, meanwhile, inhibited acetylcholinesterase with a Ki of 20.86 nanomolar, nearly eight times more potent than the reference drug tacrine, suggesting relevance to neurodegenerative disease.

The review’s authors argue that the field is undergoing a paradigm shift away from classical single-target analogue synthesis toward intentional multi-target-directed ligands, and they identify several frontiers that will define the next generation of work. Emerging designs include 5-aminopyrazole inhibitors of the deubiquitinating enzyme USP7, which drive p53-mediated tumour suppression, and tetrasubstituted 5-arylamino pyrazoles that arrest endothelial cell migration and tube formation by modulating intracellular calcium, offering selective antiangiogenic profiles without blind systemic cytotoxicity. Hybridization with HDAC-inhibiting aminobenzamides is proposed as a route around drug-resistance mechanisms. Looking ahead, the authors advocate systematically pairing automated, AI-driven QSAR models with polymeric nano-formulations and targeted protein degradation technologies such as PROTACs, a combination they believe can carry the pyrazole scaffold from academic screens into optimized, low-toxicity clinical and field-ready candidates. For a ring first celebrated more than a century ago in antipyrine, the 2025-2026 literature makes a compelling case that its most productive era may be the one just beginning.

Subject of Research: Biological evaluation of novel bioactive pyrazole derivatives in medicinal chemistry and agrochemistry

Article Title: Recent biological evaluations of novel bioactive pyrazole derivatives developed between 2025 and 2026

Article References: Recent biological evaluations of novel bioactive pyrazole derivatives developed between 2025 and 2026. (n.d.). https://doi.org/10.1007/s44371-026-00966-1

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00966-1

Keywords: pyrazole, medicinal chemistry, anticancer agents, EGFR inhibitors, COX-2 inhibitors, DPP-4 inhibitors, antimicrobial, agrochemicals, structure-activity relationships, drug discovery, nanogels, heterocyclic scaffolds

The review, led by Waqas Mohy-Ud-Din of Tianjin University together with colleagues at institutions across China, synthesizes evidence on synthetic fertilizers and pesticides alongside the contaminants that travel with them: heavy metals, microplastics and a growing suite of emerging pollutants such as antibiotic residues. Rather than treating each chemical group as a separate story, the authors organize the evidence around five shared control points that govern greenhouse gas production in soil: the supply of reactive substrates such as nitrogen and carbon, soil aeration and redox status, pH and toxicity stress, the composition of microbial functional guilds, and the effects of co-exposure when multiple contaminants arrive together.

The logic behind this framework is deceptively simple but technically consequential. Soil microbes produce nitrous oxide primarily through nitrification and denitrification, two linked arms of the nitrogen cycle whose rates depend on how much ammonium and nitrate are available, how much oxygen diffuses through soil pores, and how acidic the soil has become. Carbon dioxide fluxes track the decomposition of organic matter by heterotrophic microbes, while methane emissions in flooded paddies are set by the balance between methane-producing archaea and methane-oxidizing bacteria. Any agrochemical that shifts substrate availability, oxygen diffusion, pH or the abundance of key functional genes will, in principle, bend these fluxes.

Among all the contaminant classes examined, synthetic nitrogen fertilizers emerge as the most consistent and best understood driver, particularly of nitrous oxide. Adding reactive nitrogen directly fuels nitrifier and denitrifier communities, and decades of field and laboratory work compiled in the review show that nitrous oxide emissions rise predictably with nitrogen input, especially when over-application leaves surplus nitrate in the soil. Fertilization also acidifies soils over time, and lower pH is known to suppress the final step of denitrification, the reduction of nitrous oxide to harmless dinitrogen gas, causing incomplete denitrifiers to leak more of the potent greenhouse gas into the air. Meta-analyses cited by the authors confirm that optimizing nitrogen rates, using enhanced-efficiency fertilizers and harmonizing chemical fertilizer with manure can meaningfully cut emissions while maintaining yields.

Pesticides tell a messier story. Fungicides such as mancozeb and chlorothalonil, herbicides like bensulfuron methyl and pretilachlor, and insecticides including sulfoxaflor and thiamethoxam have all been shown to alter carbon dioxide, nitrous oxide or methane fluxes, but the direction and magnitude of the response depend on dose, soil type, water regime and the sensitivity of the resident microbial community. In flooded rice systems, some herbicides suppress methane oxidation and thereby increase methane emissions, while in aerobic soils certain fungicides inhibit denitrifiers and shift the balance of nitrogen gases. A recent study highlighted in the review also found that increasing the diversity of pesticides applied to a soil can impair broader microbial functions, raising concerns about the cumulative effects of modern multi-chemical crop protection regimes.

Heavy metals, which enter farmland through contaminated irrigation water, phosphate fertilizers that carry cadmium impurities, industrial deposition and animal manures, add another layer of complexity. Metal toxicity can inhibit specific steps of the nitrogen cycle, and studies of metal-polluted paddy soils show altered abundance and composition of ammonia-oxidizer and denitrifier communities. Intriguingly, the review notes that water regime modulates these effects: cadmium, for example, appears to disrupt nitrogen transformation processes more strongly under non-flooded than flooded conditions, and water management changes the microbial mechanisms by which nitrous oxide is produced in metal-contaminated paddies. Some work even suggests that bacterivorous protists can suppress nitrification and nitrous oxide emissions in cadmium-polluted soils through negative feedback loops, hinting at unexpected biological levers within contaminated systems.

Microplastics, perhaps the most visually striking of the associated contaminants, have accumulated in agricultural soils through decades of plastic film mulching, with some fields now hosting substantial macro- and microplastic loads after more than thirty years of continuous mulch use. The evidence on their climatic consequences is heterogeneous. Polyethylene microplastics have been reported to increase nitrous oxide emissions from paddy soils and to alter microbial functional gene abundances, while biodegradable plastics such as PBAT and polylactic acid can stimulate carbon dioxide emissions by enhancing organic matter decomposition, or in some cases induce negative priming that improves carbon sequestration. Effects also depend on interactions with other amendments: co-existence with biochar or hydrochar can stimulate methane emissions while suppressing nitrous oxide, and combinations with earthworms or antibiotics produce outcomes that no single-contaminant experiment would predict.

Emerging contaminants, particularly veterinary and human antibiotics that reach fields through manure and wastewater irrigation, round out the picture. Tetracyclines, sulfonamides and quinolones have all been shown to perturb nitrogen cycling in soil. Tetracycline and sulfamethazine can alter dissimilatory nitrate reduction pathways and increase nitrous oxide release from rice fields, while ciprofloxacin contamination appears to selectively favor antibiotic-resistant denitrifiers that drive nitrous oxide production. Yet the dose-response relationships are not straightforward: some studies find that environmentally relevant, even ultralow, antibiotic exposures shift nitrate and nitrous oxide fluxes, whereas chronic low-level exposure in sediments can alter bacterial communities without changing denitrification rates. Plants, too, can mitigate nitrous oxide emissions from antibiotic-contaminated soils, underscoring how many interacting variables govern the final flux.

The central insight of the review is that these seemingly disparate contaminant stories become coherent when read through the five shared control points. Fertilizers act overwhelmingly through substrate supply, acidification and nitrogen-cycling microbes, which is why their effects are consistent across studies. Pesticides, heavy metals, microplastics and emerging contaminants act more diffusely through toxicity, changes to soil structure and hydrology, dose-dependent stress and co-exposure, which is why their effects scatter across the literature. This reframing matters for mitigation: interventions that target the shared control points, such as optimized nitrogen management, alternate wetting and drying in rice paddies, reduced tillage, diversified crop rotations and integrated nutrient management, can cut emissions regardless of which contaminant cocktail a particular field carries, while contaminant-specific strategies remain necessary for hotspots of metal or plastic pollution.

The authors are candid about what remains unknown. Multi-contaminant interactions, in which heavy metals, microplastics, pesticides and antibiotics co-occur as they do in real fields, are grossly under-studied compared with single-stressor experiments. Long-term field observations are scarce, leaving open questions about whether laboratory responses persist under real farming conditions and how climate change itself feeds back on contaminant behavior and microbial emissions. Closing these gaps, the review concludes, will require mechanistic experiments designed around the shared control points, sustained long-term monitoring networks, and mitigation frameworks that treat agrochemicals and their associated contaminants as an integrated system rather than a list of separate pollutants. For a sector responsible for a substantial share of global greenhouse gas emissions, the message is clear: the chemistry we put in our fields, and everything that chemistry drags along with it, is quietly shaping the climate math of agriculture.

Subject of Research: Mechanisms linking agrochemicals and associated soil contaminants to greenhouse gas emissions in agricultural ecosystems

Article Title: Linking agrochemicals and associated contaminants to greenhouse gas emissions in agricultural ecosystems

Article References: Mohy-Ud-Din, W., Yan, Z., Ge, Z., Zhang, W., Yan, S., Qi, Y., & Liu, Y.-R. (2026). Linking agrochemicals and associated contaminants to greenhouse gas emissions in agricultural ecosystems. Plant and Soil. https://doi.org/10.1007/s11104-026-09153-8

Image Credits: AI Generated

DOI: 10.1007/s11104-026-09153-8

Keywords: agrochemicals, greenhouse gases, nitrous oxide, soil microbiology, fertilizers, pesticides, heavy metals, microplastics, antibiotics, nitrogen cycle, agriculture, climate change

The scale of the problem is staggering. Regulatory agencies typically evaluate the parent active ingredients of pesticides and medicines, but environmental monitoring studies repeatedly show that degradation products can persist longer, travel further, and sometimes exceed the concentrations of the original compounds in groundwater and surface water. Classical examples include the transformation products of the herbicide atrazine, which can linger in aquifers for decades, and the metabolites of veterinary antibiotics that accumulate in soils and drive antimicrobial resistance. For pharmaceuticals, human metabolites excreted after drug treatment pass largely unchanged through wastewater treatment plants and re-enter drinking water sources. Traditionally, assessing each of these molecules would require years of laboratory animal testing, analytical method development, and environmental fate studies—an approach that is simply too slow and expensive for the thousands of metabolites already known and the many more still being discovered.

The study, authored by researchers working at the intersection of cheminformatics and environmental toxicology, argues that the moment has come to shift toxicity assessment from a purely experimental discipline to a hybrid one in which computational predictions guide and prioritize experimental work. The authors assemble and analyze the principal computational strategies now available for this task, ranging from classical quantitative structure–activity relationship models, which relate molecular descriptors such as lipophilicity, electronic properties, and topological indices to biological endpoints, to modern deep learning architectures capable of learning toxicological patterns directly from chemical structures. Graph neural networks, in particular, have emerged as a powerful tool because they represent molecules as networks of atoms and bonds, allowing algorithms to learn which substructures are associated with carcinogenicity, mutagenicity, endocrine disruption, or aquatic toxicity.

A central theme of the article is the diversity of toxicity endpoints that must be considered when evaluating agrochemical and pharmaceutical metabolites. Acute toxicity matters, but chronic effects are often more insidious and harder to detect. The authors discuss computational approaches for predicting genotoxicity, developmental and reproductive toxicity, endocrine receptor binding, skin sensitization, and ecotoxicological outcomes in organisms such as fish, daphnids, and algae. Machine learning classifiers trained on curated datasets from sources such as regulatory toxicity databases and public repositories can flag metabolites that share structural alerts with known toxins. At the same time, the article stresses that no single model suffices: predictions must be triangulated across multiple endpoints, and read-across approaches—inferring the properties of an unknown metabolite from structurally similar chemicals with experimental data—remain an essential complement when training data are sparse.

One of the most technically interesting contributions is the discussion of how metabolite-specific challenges strain conventional models. Machine learning models are typically trained on parent compounds, and metabolites often sit in chemical regions poorly covered by training data—a problem the community calls applicability domain violation. Degradation products may be smaller, more polar, or carry unusual functional groups introduced by photolysis or biotransformation, making naively applied predictions unreliable. The article describes strategies to address this, including data augmentation with transformation product libraries, uncertainty quantification methods that indicate when a model is extrapolating beyond its competence, and ensemble approaches that combine the votes of many models to produce calibrated confidence estimates. In silico metabolism simulators, which predict the likely transformation pathways of parent compounds, extend the framework further by generating lists of candidate metabolites that can then be prioritized for toxicity screening even before they are detected in the environment.

Molecular docking and other structure-based computational techniques also feature prominently. For endocrine disruption and receptor-mediated toxicity, the authors explain how metabolites can be docked into the binding pockets of estrogen, androgen, and thyroid hormone receptors, and how molecular dynamics simulations refine these snapshots into dynamic pictures of binding stability. Combining docking scores with machine learning-derived descriptors produces hybrid models that outperform either approach alone. Quantum chemical calculations, including density functional theory, add another layer of mechanistic insight by quantifying the reactivity of metabolites toward biological nucleophiles such as DNA bases and proteins, which is central to understanding genotoxic and sensitizing potential. This multi-layered computational pipeline mirrors how a toxicologist thinks, but executes in minutes what would otherwise take months of bench work.

The article does not shy away from the limitations of the field. Data quality remains the Achilles’ heel of machine learning toxicity prediction: experimental datasets are heterogeneous, drawn from different protocols, species, and laboratories, and labeling inconsistencies can propagate silently into models. Class imbalance is another persistent difficulty, since verified toxic molecules are far outnumbered by benign ones, biasing classifiers toward false negatives—arguably the most dangerous kind of error in safety assessment. Interpretability is equally critical, because a black-box prediction that a metabolite is carcinogenic carries little regulatory weight unless the model can explain which structural features drove the conclusion. The authors highlight techniques such as attention-based attribution, SHAP-style feature importance analysis, and substructure highlighting as ways to make deep models transparent enough for use in regulatory contexts, and they call for standardized benchmarks of metabolite toxicity data to allow fair comparison of competing methods.

Perhaps the most consequential part of the study is its forward-looking roadmap for regulatory integration. The authors envision a tiered workflow in which computational screening of transformation products happens early, identifying high-risk metabolites for targeted analytical monitoring and focused experimental testing. This mirrors emerging regulatory thinking in Europe and North America, where in silico evidence is increasingly accepted as supporting information in risk assessment frameworks for plant protection products and pharmaceuticals in the environment. Artificial intelligence could dramatically shorten the time between the introduction of a new pesticide or drug and the characterization of its full transformation footprint, enabling safer molecular design from the outset. The concept of benign-by-design chemistry—engineering molecules that degrade into genuinely harmless products—becomes tractable when toxicity predictions are fast, cheap, and accurate enough to guide synthesis decisions in real time.

For the public, the stakes are concrete: cleaner drinking water, safer food residues, and reduced chemical pressure on already stressed ecosystems. For industry, the framework offers a path to avoid costly late-stage failures and regulatory surprises. And for the scientific community, the article consolidates a rapidly moving field, connecting the dots between cheminformatics, deep learning, environmental analytical chemistry, and toxicology in a way that few previous reviews have attempted. As artificial intelligence continues to penetrate every corner of chemistry, this work makes a persuasive case that the transformation products of our agrochemicals and medicines—long the invisible residues of modern life—can finally be brought into the light of systematic, predictive safety science, before the next hidden toxin makes headlines for the wrong reasons.

Subject of Research: AI-driven computational prediction of the toxicity of agrochemical and pharmaceutical metabolites

Article Title: Toxicity assessment of agrochemical and pharmaceutical metabolites using artificial intelligence machine learning and computational approaches

Article References: Jana, S., Matore, B. W., Murmu, A., Gawande, P., Shukla, D., Kumar, A., Singh, J., & Roy, P. P. (2026). Toxicity assessment of agrochemical and pharmaceutical metabolites using artificial intelligence machine learning and computational approaches. Discover Chemistry, 3(1), Article 533. https://doi.org/10.1007/s44371-026-00993-y

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00993-y

Keywords: artificial intelligence, machine learning, toxicity prediction, agrochemicals, pharmaceuticals, metabolites, computational chemistry, QSAR, deep learning, environmental toxicology, cheminformatics, risk assessment